OTC:DFPH | Free Cash Flow | Starling Oncology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.22M$1.04M-$3.26M
2025-12-31$3.23M$1.06M$2.17M
2025-03-31-$4.99M$328,000.00-$5.32M
2024-12-31$4.19M$1.76M$2.43M
2024-03-31-$15.88M$610,000.00-$16.49M
2023-12-31-$3.89M$861,000.00-$4.75M
2023-03-31-$15.45M$1.84M-$17.29M
2022-12-31-$14M$2M-$15.99M
2022-03-31-$16.98M$1M-$17.98M-93.24%
2021-12-31-$23.34M$871,000.00-$24.21M
2021-03-31$464,000.00$619,000.00-$155,000.00
2020-12-31$1.01M
2020-03-31-$28,750.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$24.59M$3.2M-$27.79M
2024-12-31-$26.54M$3.79M-$30.33M
2023-12-31-$36.32M$4.57M-$40.88M
2022-12-31-$61.76M$5.53M-$67.29M-44266.45%
2021-12-31-$32.68M$2.85M-$35.53M
2020-12-31$508,000.00$1.19M-$686,000.00